Vanda Pharmaceuticals, Inc. (VNDA)
5.39
+0.19
(+3.65%)
USD |
NASDAQ |
Dec 05, 16:00
5.45
+0.06
(+1.11%)
After-Hours: 20:00
Vanda Pharmaceuticals Shareholders Equity (Quarterly): 466.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| ADMA Biologics, Inc. | 431.19M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| Exelixis, Inc. | 2.161B |
| Anavex Life Sciences Corp. | 94.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 601.14M |
| Total Liabilities (Quarterly) | 135.14M |
| Debt to Equity Ratio | 0.0234 |
| Current Ratio | 3.118 |
| Net Debt Paydown Yield | -0.17% |